Abstract:
Rotavirus (RV) is the leading cause of severe gastroenteritis in children under 5 years of age. In this chapter we will document the burden of rotavirus gastroenteritis in the 27 countries of the European Union.
Data on rotavirus disease burden is lacking for about half of the countries of the European Union. The available data for the other half show differences that do not necessarily reflect country-specific differences, but that may also be due to differences in study characteristics and quality. Based on the available literature, the annual incidence of RV disease in the European Union ranges from 0.06–4.15% of the children aged <5 years seeking ambulatory care, 0–2.65% of the children aged <5 years visiting emergency departments, 0.03–1.19% of the children aged <4/5 years being hospitalized for rotavirus, and 0.5–14 children per million children aged <3/5 years that die due to RV infection. Information on children experiencing disease but not seeking professional medical care is lacking for the European Union. Studies on nosocomial RV infections are numerous, but difficult (if not impossible) to interpret and compare, because of very different methodologies and contexts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AGE:
-
acute gastroenteritis
- EU:
-
European Union
- GP:
-
general practitioner
- ICD-9:
-
International Classification of Disease, ninth edition
- NRV:
-
nosocomial rotavirus infection
- O:
-
outpatient visit
- P:
-
pediatrician
- PROTECT:
-
Pediatric ROTavirus European CommiTee
- RV:
-
rotavirus
- RVGE:
-
rotavirus gastroenteritis
References
Bilcke J, Van Damme P, Beutels P. (2008). Med Decis Making. doi:10.1177/0272989X08324955
Bilcke J, Van Damme P, De Smet F, Hanquet G, Van Ranst M, Beutels P. (2008). Eur J Ped 167(12): 1409–1419.
Bilcke J, Beutels P, De Smet F, Hanquet G, Van Ranst M, Van Damme P. (2007). KCE reports vol.54C. accessed November 6th 2008
Chandran A, Heinzen RR, Santosham M, Siberry GK. (2006). J Pediatr. 149: 441–447.
Cilla G, Perez-Trallero E, Lopez-Lopategui MC, Gilsetas A, Gomariz M. (2000). Epidemiol Infect. 125: 677–683.
Crowley DS, Ryan MJ, Wall PG. (1997). Commun Dis Rep CDR Rev 7: R82–R86.
de Wit MA, Koopmans MP, Blij JF, van der van Duynhoven YT. (2000). Clin Infect Dis. 31: 698–704.
de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Bartelds AI, van Duynhoven YT. (2001a). Emerg Infect Dis. 7: 82–91.
de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Vinje J, van Duynhoven YT. (2001b). Clin Infect Dis. 33: 280–288.
de Zoysa I, Feachem RG. (1985). Bull World Health Organ 63: 569–583.
Dennehy PH. (2007). Vaccine 25: 3137–3141.
Ehlken B, Laubereau B, Karmaus W, Petersen G, Rohwedder A, Forster J. (2002). Acta Paediatr. 91: 769–775.
Fischer TK. (2001). Acta Paediatr. 90: 1073–1075.
Fischer TK, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, Molbak K, Sommerfelt H. (2002). J Infect Dis. 186: 593–597.
Fischer TK, Nielsen NM, Wohlfahrt J, Paerregaard A. (2007). Emerg Infect Dis. 13: 855–859.
Floret D, Lina B, Pinchinat S, Billaud G, Ait-Belghiti F, Largeron N, Bellemin B, Trang CN, Fau C, Gaspard C, Mamoux V, Marcelon L. (2006). Eur J Pediatr. 165: 905–906.
Foppa IM, Karmaus W, Ehlken B, Fruhwirth M, Heininger U, Plenge-Bonig A, Forster J. (2006). Infect Control Hosp Epidemiol. 27: 633–635.
Fourquet F, Desenclos JC, Maurage C, Baron S. (2003). Arch Pediatr. 10: 861–868.
Fruhwirth M, Heininger U, Ehlken B, Petersen G, Laubereau B, Moll-Schuler I, Mutz I, Forster J. (2001a). Pediatr Infect Dis. J 20: 784–791.
Fruhwirth M, Karmaus W, Moll-Schuler I, Brosl S, Mutz I. (2001b). Arch Dis Child. 84: 393–397.
Gil A, Carrasco P, Jimenez R, San-Martin M, Oyaguez I, Gonzalez A. (2004). Vaccine 22: 2221–2225.
Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. (2006). Lancet. 368: 323–332.
Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z, Giaquinto C, Grimprel E. (2006). Pediatr Infect Dis J. 25: S12–S21.
Hsu VP, Staat MA, Roberts N, Thieman C, Bernstein DI, Bresee J, Glass RI, Parashar UD. (2005). Pediatrics. 115: 78–82.
Huet F, Largeron N, Trichard M, Miadi-Fargier H, Jasso-Mosqueda G. (2007). Vaccine. 25: 6348–6358.
Jit M, Edmunds WJ. (2007). Vaccine. 25: 3971–3979.
Jit M, Pebody R, Chen M, Andrews N, Edmunds WJ. (2007). Hum Vaccin. 3: 23–26.
Johansen K, Bennet R, Bondesson K, Eriksson M, Hedlund KO, De Verdier Klingenberg K, Uhnoo I, Svensson L. (1999). Acta Paediatr. 88: 20–23.
Koopmans M, Brown D. (1999). Acta Paediatr. 88: 14–19.
Lynch M, O’Halloran F, Whyte D, Fanning S, Cryan B, Glass RI. (2001). Pediatr Infect Dis J. 20: 693–698.
Mata L, Simhon A, Urrutia JJ, Kronmal RA, Fernandez R, Garcia B. (1983). J Infect Dis. 148: 452–461.
Mrukowicz JZ, Krobicka B, Duplaga M, Kowalska-Duplaga K, Domanski J, Szajewska H, Kantecki M, Iwanczak F, Pytrus T. (1999). Acta Paediatr. 88: 53–60.
Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. (2003). Emerg Infect Dis. 9: 565–572.
Parashar UD, Gibson CJ, Bresse JS, Glass RI. (2006). Emerg Infect Dis. 12: 304–306.
Piednoir E, Bessaci K, Bureau-Chalot F, Sabouraud P, Brodard V, Andreoletti L, Bajolet O. (2003). J Hosp Infect. 55: 190–195.
PROTECT(2006). Epidemiol Infect. 134: 908–916.
Rendi-Wagner P, Kundi M, Mikolasek A, Mutz I, Zwiauer K, Wiedermann U, Vecsei A, Kollaritsch H. (2006). Wien Klin Wochenschr. 118: 280–285.
Riordan FA, Quigley T. (2004). J Infect. 49: 13–16.
Ryan MJ, Ramsay M, Brown D, Gay NJ, Farrington CP, Wall PG. (1996). J Infect Dis. 174 Suppl 1: S12–S18.
Salo H, Ollgren J, Linna M, Sintonen H, Kilpi T. (2007). Economic evaluation of rotavirus vaccination in Finland. poster, EUPHA, Helsinki.
Simhon A, Mata L, Vives M, Rivera L, Vargas S, Ramirez G, Lizano L, Catarinella G, Azofeifa J. (1985). J Infect Dis. 152: 1134–1142.
Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T. (2006). Pediatr Infect Dis J. 25: S7–S11.
Szucs G, Uj M, Mihaly I, Deak J. (1999). Acta Paediatr. 88: 61–65.
Tran MN. (2006). Survey of the deaths due to acute gastro-enteritis avoidable with the rotavirus vaccine, France, poster, EPIET Scientific Seminar, Menorca. France, Nov 2004–Mar 2005.
Van Damme P, Wielen M, Van der Ansaldi F, Desgrandchamps D, Domingo JD, Sanchez FG, Gray J, Haditsch M, Johansen K, Lorgelly P, Lorrot M, Parez N, Reschke V, Rose M. (2006). Lancet Infect Dis. 6: 805–812.
Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Wielen M. Van der (2007). J Infect Dis. 195 Suppl 1: S4–S16.
Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. (1996). N Engl J Med. 335: 1022–1028.
Vesikari T, Rautanen T, Von Bonsdorff CH. (1999). Acta Paediatr. 88: 24–30.
Visser LE, Cano Portero R, Gay NJ, Martinez Navarro JF. (1999). Acta Paediatr. 88: 72–76.
Zheng BJ, Lo SK, Tam JS, Lo M, Yeung CY, Ng MH. (1989). J Clin Microbiol. 27: 2083–2090.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Bilcke, J., Damme, P.V., Beutels, P. (2010). The Burden of Rotavirus Acute Gastroenteritis in Europe. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_70
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_70
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine